bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.07.24.501309

Early β-amyloid accumulation and hypoconnectivity in the default mode network are related to its disengagement from global brain activity

Han, F.·Liu, X.·Mailman, R. B.·Huang, X.
View original source ↗Export metadata ↓

Abstract

AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSImportanceC_ST_ABSThe specific pattern/trajectory of {beta}-amyloid (A{beta}) pathology spreading in Alzheimers disease (AD), from default mode network (DMN) regions to sensory-motor areas, is well known, but poorly understood. ObjectiveTo determine if resting-state global brain activity is linked to early A{beta} deposition in the DMN. DesignThis is a retrospect analysis of multi-modal and longitudinal data from the Alzheimers disease Neuroimaging Initiative (ADNI) cohort. SettingThe ADNI was a multicenter project involving 63 research centers. ParticipantsThe study included 144 participants (72.6 {+/-} 7.5 years; 73 females) of whom 28 were controls, 21 had significant memory concerns, 72 had cognitive impairment (N=72), and 23 had AD. There were both baseline and 2-year follow-up data for A{beta}-PET for 112 of the subjects. They were classified into following stages based on the CSF A{beta}42 (CSF+: <192 ng/L) and cortical A{beta} (PET+: >0.872 SUVR) levels: non-A{beta}-accumulators (CSF-/PET-); early-A{beta}-accumulators (CSF+/PET-); and late-A{beta}-accumulators (CSF+/PET+). ExposureResting-state brain activity was assessed by functional magnetic resonance imaging (rsfMRI), whereas glymphatic function was estimated by the coupling between fMRI blood-oxygen-level-dependent (BOLD) signals and CSF movements. Main Outcomes and MeasuresCortical A{beta} accumulation measured by 18F-AV45 amyloid-positron emission tomography (PET), CSF A{beta}42, and total and phosphorylated tau protein levels in all participants. ResultsGlymphatic function assessed by fMRI was strongly ({rho} > 0.43, P < 0.042) associated with various markers of protein aggregation in early A{beta} accumulators in whom A{beta} just begins to accumulate cortically in the DMN. Among these early accumulators, the preferential A{beta} accumulation in the DMN regions in the subsequent two years was correlated with lower gBOLD signal ({rho} = 0.51, P = 0.027) and lower local glymphatic function ({rho} = 0.48, P = 0.041) in the same regions at baseline. Conclusions and RelevanceResting-state global brain activity and related glymphatic function are linked to A{beta} pathology, particularly its preferential deposition in the DMN at the earliest AD stages. This suggests potential novel early therapeutic directions that might provide disease modification. KO_SCPLOWEYC_SCPLOW PO_SCPLOWOINTSC_SCPLOWO_ST_ABSQuestionC_ST_ABSWhy does the {beta}-amyloid (A{beta}) plaque deposit preferentially in the default mode network (DMN) regions at early preclinical stages of Alzheimers disease? FindingsIn this analytic observational cohort study with 144 subjects, we found that the preferential reduction of global resting-state brain activity in the DMN, as well as its coupling with cerebrospinal fluid movement, was significantly correlated with the preferential A{beta} accumulation in these DMN regions among 19 subjects with early A{beta} accumulation. MeaningResting-state global brain activity plays a role in the early A{beta} accumulation in the DMN, presumably due to its involvement in glymphatic clearance.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Han, F., Liu, X., Mailman, R. B., Huang, X.. 2022-07-25. Early β-amyloid accumulation and hypoconnectivity in the default mode network are related to its disengagement from global brain activity. https://doi.org/10.1101/2022.07.24.501309

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗